Advanced in Transient Ischemic Attack (TIA)

Juan F. Arenillas

Valladolid, CL, ES 
Advanced in Transient Ischemic Attack (TIA)
Valladolid, CL, ES 
OverviewLocationsClinical Research

Overview

Juan Arenillas practices in Valladolid, Spain. Mr. Arenillas is rated as an Advanced expert by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Stroke, Transient Ischemic Attack (TIA), COVID-19, Thrombectomy, and Stent Placement.

His clinical research consists of co-authoring 151 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles and participated in 1 clinical trial in the study of Transient Ischemic Attack (TIA).

Gender
Male

Locations

Valladolid, CL, Spain
Other Locations
Castilla, MD, Spain
Madrid, MD, Spain
Fundacio Docència I Recerca Mutuaterrassa, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Tenecteplase, Antiplatelet Monotherapy
Study Phase: Phase 3
Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study
Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study
Enrollment Status: Terminated
Publish Date: July 25, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

151 Total Publications

Targeting Innate Immune Memory for Stroke Prevention and Prognosis.
Targeting Innate Immune Memory for Stroke Prevention and Prognosis.
Journal: Stroke
Published: September 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Arenillas's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile